Are you Dr. Maenza?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 18 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
325 9th Ave
Seattle, WA 98104Phone+1 206-744-5100
Summary
- Dr. Janine Maenza, MD is an infectious disease specialist in Seattle, Washington. She is currently licensed to practice medicine in Washington and Maryland. She is affiliated with UW Medicine/Harborview Medical Center.
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 1993 - 1996
University of Virginia Medical CenterResidency, Internal Medicine, 1990 - 1993
University of Missouri-Columbia School of MedicineClass of 1990
Certifications & Licensure
WA State Medical License 1999 - 2026
MD State Medical License 1996 - 2001- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.William O Hahn, K Rachael Parks, Mingchao Shen, Gabriel Ozorowski, Holly Janes
The Journal of Experimental Medicine. 2024-10-07 - 1 citationsAntigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation.Jaimy Joy, Ana Gervassi, Lennie Chen, Brent Kirshenbaum, Sheila Styrchak
The Journal of Clinical Investigation. 2024-06-04 - 2 citationsA HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals.Nathan B Erdmann, Wilton B Williams, Stephen R Walsh, Nicole Grunenberg, Paul T Edlefsen
Medrxiv. 2024-03-18
Grant Support
- Virological And Immunological Events In Acute/Early HIV-1 InfectionNational Center For Research Resources2005–2007
- Trial Of Nandrolone Decanoate In Women With HIV CachexiaNational Center For Research Resources2000–2002
- Chriron Quantiplex HIV 1 RNA 3 0 AssayNational Center For Research Resources1999–2002
- Effetcs Of Remune And Antiviral Therapy On HIV 1 Specific ImmunogenicityNational Center For Research Resources1998–2002
- ACTG 378: Effect Of Staggered Dosing On Pharmacokinetics Of Protease InhibitorNational Center For Research Resources1999
- ACTG 343--Protective Ransomized Double Blind Three Maintenance RegimensNational Center For Research Resources1998–1999
